/θraɪv/ thrive, from Old Norse þrífask:
to grasp, to grow, to flourish
Helping healthcare companies thryve
A European lower mid-market healthcare buyout investor. We back proven, EBITDA-positive companies and grow them through hands-on operational value creation.
Who we are
We are operator-investors. Our team combines private equity, C-level operating experience and scientific depth, so we understand the science and the trends behind emerging healthcare technologies and turn that understanding into sustainable growth for the companies we back.
What we look for
Proven businesses ready for their next stage
- A clear, sustainable growth trajectory in niches that classic buyout specialists find hard to identify, understand or access
- Historic revenue growth, positive EBITDA and a stable customer base that has built the offering into its own value chain
- A scale-up plan or M&A strategy that needs external capital to roll out a proven business model
- European category leaders in niche products or services, with room to expand along the value chain, across Europe and into the US
- Strong exit perspectives with strategic acquirers, mapped at entry and built into the value creation roadmap
- Equity ticket
- EUR 10–30m
- Ownership
- Majority buyouts
- Profile
- EBITDA-positive
- Geography
- Europe